Data suggest that progesterone may improve smoking cessation outcomes perhaps by reducing
impulsive behavior. However, the clinical literature on this topic is lacking. Therefore, in
Project I we are proposing a double-blind randomized controlled trial to assess the role of
exogenous progesterone on impulsivity and smoking cessation in a sample of males and females
who are motivated to quit smoking.